These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11530355)

  • 1. Models for the population biology and control of human onchocerciasis.
    Basáñez MG; Ricárdez-Esquinca J
    Trends Parasitol; 2001 Sep; 17(9):430-8. PubMed ID: 11530355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A stochastic model for the aggregation of Onchocerca volvulus in nodules.
    Duerr HP; Dietz K; Buttner DW; Schulz-Key H
    Parasitology; 2001 Aug; 123(Pt 2):193-201. PubMed ID: 11510685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population biology of human onchocerciasis.
    Basáñez MG; Boussinesq M
    Philos Trans R Soc Lond B Biol Sci; 1999 Apr; 354(1384):809-26. PubMed ID: 10365406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population dynamics of onchocerca volvulus microfilariae in human host after six years of drug control.
    Opara KN; Fagbemi BO
    J Vector Borne Dis; 2008 Mar; 45(1):29-37. PubMed ID: 18399314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of Onchocerca volvulus in humanized NSG mice and detection of parasite biomarkers in urine and serum.
    Patton JB; Bennuru S; Eberhard ML; Hess JA; Torigian A; Lustigman S; Nutman TB; Abraham D
    PLoS Negl Trop Dis; 2018 Dec; 12(12):e0006977. PubMed ID: 30540742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modelling Anti-Ov16 IgG4 Antibody Prevalence as an Indicator for Evaluation and Decision Making in Onchocerciasis Elimination Programmes.
    Lont YL; Coffeng LE; de Vlas SJ; Golden A; de Los Santos T; Domingo GJ; Stolk WA
    PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005314. PubMed ID: 28114304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Onchocerca-Simulium complexes in Venezuela: can human onchocerciasis spread outside its present endemic areas?
    Basáñez MG; Yarzábal L; Frontado HL; Villamizar NJ
    Parasitology; 2000 Feb; 120 ( Pt 2)():143-60. PubMed ID: 10726276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elimination of human onchocerciasis: history of progress and current feasibility using ivermectin (Mectizan(®)) monotherapy.
    Cupp EW; Sauerbrey M; Richards F
    Acta Trop; 2011 Sep; 120 Suppl 1():S100-8. PubMed ID: 20801094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Individual host factors associated with Onchocerca volvulus microfilarial densities 15, 80 and 180 days after a first dose of ivermectin.
    Pion SD; Grout L; Kamgno J; Nana-Djeunga H; Boussinesq M
    Acta Trop; 2011 Sep; 120 Suppl 1():S91-9. PubMed ID: 20497765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Density-dependent mortality of the human host in onchocerciasis: relationships between microfilarial load and excess mortality.
    Walker M; Little MP; Wagner KS; Soumbey-Alley EW; Boatin BA; Basáñez MG
    PLoS Negl Trop Dis; 2012; 6(3):e1578. PubMed ID: 22479660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment and monitoring of onchocerciasis in Latin America.
    Rodríguez-Pérez MA; Unnasch TR; Real-Najarro O
    Adv Parasitol; 2011; 77():175-226. PubMed ID: 22137585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic polymorphism of the beta-tubulin gene of Onchocerca volvulus in ivermectin naïve patients from Cameroon, and its relationship with fertility of the worms.
    Bourguinat C; Pion SD; Kamgno J; Gardon J; Gardon-Wendel N; Duke BO; Prichard RK; Boussinesq M
    Parasitology; 2006 Feb; 132(Pt 2):255-62. PubMed ID: 16197589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human onchocerciasis: notes on the history, the parasite and the life cycle.
    Nelson GS
    Ann Trop Med Parasitol; 1991 Feb; 85(1):83-95. PubMed ID: 1888224
    [No Abstract]   [Full Text] [Related]  

  • 14. [Molecular approaches to the control of onchocerciasis in Mexico].
    Rodríguez-Pérez MA
    Rev Latinoam Microbiol; 2005; 47(3-4):112-29. PubMed ID: 17061536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent updates on onchocerciasis: diagnosis and treatment.
    Udall DN
    Clin Infect Dis; 2007 Jan; 44(1):53-60. PubMed ID: 17143815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The population dynamics of Onchocerca volvulus in the human host.
    Duke BO
    Trop Med Parasitol; 1993 Jun; 44(2):61-8. PubMed ID: 8367667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Research notes from the Onchocerciasis Chemotherapy Research Centre, Ghana.
    Awadzi K
    Ann Trop Med Parasitol; 1997 Oct; 91(7):703-11. PubMed ID: 9625924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Density-dependent processes in the transmission of human onchocerciasis: intensity of microfilariae in the skin and their uptake by the simuliid host.
    Basáñez MG; Boussinesq M; Prod'hon J; Frontado H; Villamizar NJ; Medley GF; Anderson RM
    Parasitology; 1994 Jan; 108 ( Pt 1)():115-27. PubMed ID: 8152850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transmission intensity and the patterns of Onchocerca volvulus infection in human communities.
    Basáñez MG; Collins RC; Porter CH; Little MP; Brandling-Bennett D
    Am J Trop Med Hyg; 2002 Dec; 67(6):669-79. PubMed ID: 12518860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a preliminary in vitro drug screening assay based on a newly established culturing system for pre-adult fifth-stage Onchocerca volvulus worms.
    Voronin D; Tricoche N; Jawahar S; Shlossman M; Bulman CA; Fischer C; Suderman MT; Sakanari JA; Lustigman S
    PLoS Negl Trop Dis; 2019 Jan; 13(1):e0007108. PubMed ID: 30653499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.